Intraoperative and postoperative surgical complications after ureteroscopy, retrograde intrarenal surgery, and percutaneous nephrolithotomy: a systematic review

医学 经皮肾镜取石术 输尿管镜检查 外科 围手术期 并发症 不利影响 泌尿系统 经皮 输尿管 内科学
作者
Antonio Andrea Grosso,Francesco Sessa,Riccardo Campi,Lorenzo Viola,Paolo Polverino,Alfonso Crisci,Matteo Salvi,Evangelos Liatsikos,O. Angerri Feu,Fabrizio Di Maida,R. Tellini,Olivier Traxer,Andrea Cocci,Andrea Mari,Cristian Fiori,Francesco Porpiglia,Marco Carini,Agostino Tuccio,Andrea Minervini
出处
期刊:Minerva urology and nephrology [Edizioni Minerva Medica]
卷期号:73 (3) 被引量:73
标识
DOI:10.23736/s2724-6051.21.04294-4
摘要

Retrograde ureteroscopy (URS), intra-renal surgery (RIRS) and percutaneous nephrolithotomy (PCNL) represent routine interventions for the treatment of ureteral and renal stones, although at times associated with serious adverse events. Of note, the evidence on perioperative complications after these procedures remains sparse and controversial. Moreover, there is a lack of standardized reporting of adverse events using uniform systems. The aim of the present study was to systematically review of the available evidence on URS/RIRS and PCNL for the surgical treatment of urinary stone, assessing the incidence of intra- and postoperative events, classified according to the modified Clavien-Dindo scale.A systematic review of the literature was performed according to PRISMA recommendations and was conducted on intra- and postoperative complications, as well as on their management, following URS, RIRS and PCNL procedures, particularly focusing on major events.Overall, 26 studies (13 on URS/RIRS and 11 on PCNL) met the inclusion criteria and were evaluated. The highest intraoperative complication rate was 11.5% and 8.5% for RIRS and PCNL, respectively. Major complication rate following URS/RIRS and PCNL ranged between 0.3-31.7% and 2-17.1%, respectively. The most frequent adverse events were obstructive pyelonephritis or urinary leakage requiring the placement of a double J stent or a drainage. Among PCNLs series, life-threatening adverse events have also been reported, including bleeding requiring renal angioembolization and urothorax.Despite the inclusion of series using a standardized reporting system, the complication rate after URS/RIRS/PCNL remains extensively heterogeneous in the literature; in addition, a non-negligible proportion of studies did not characterize the adverse events nor report the actual management strategy to solve them. Future research is needed to standardize the classification and reporting of surgical complications after endourological procedures (taking into consideration the surgeon's experience and skills), aiming to improve patient counseling and potentially the strategy for their prevention.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Unlung完成签到,获得积分10
刚刚
科研通AI6.1应助哈哈采纳,获得10
1秒前
星辰大海应助潇洒从阳采纳,获得10
1秒前
1秒前
2秒前
酷炫的幻丝完成签到 ,获得积分10
2秒前
酷波er应助风过大泽采纳,获得10
2秒前
木佑发布了新的文献求助10
2秒前
3秒前
MouLi完成签到,获得积分10
3秒前
HHHHH发布了新的文献求助10
4秒前
繁荣的洋葱完成签到,获得积分10
4秒前
大个应助YanXuanhua采纳,获得10
5秒前
5秒前
骄傲yy完成签到,获得积分10
7秒前
7秒前
qqqq22发布了新的文献求助10
7秒前
xrl完成签到 ,获得积分10
7秒前
fuchao完成签到,获得积分10
7秒前
8秒前
赘婿应助xiaohaitang采纳,获得10
8秒前
8秒前
10秒前
桐桐应助百里幻竹采纳,获得10
10秒前
Ava应助热情的远锋采纳,获得10
10秒前
dx3906发布了新的文献求助10
11秒前
852应助lhdd采纳,获得10
12秒前
潇洒从阳发布了新的文献求助10
12秒前
辞清完成签到 ,获得积分10
12秒前
kyt完成签到,获得积分10
12秒前
13秒前
高冷的薯片儿完成签到,获得积分10
13秒前
13秒前
13秒前
junc完成签到,获得积分10
14秒前
14秒前
14秒前
林墨风发布了新的文献求助20
14秒前
花海发布了新的文献求助10
14秒前
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Digital Twins of Advanced Materials Processing 2000
Weaponeering, Fourth Edition – Two Volume SET 2000
Polymorphism and polytypism in crystals 1000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6024034
求助须知:如何正确求助?哪些是违规求助? 7654213
关于积分的说明 16174960
捐赠科研通 5172479
什么是DOI,文献DOI怎么找? 2767567
邀请新用户注册赠送积分活动 1751010
关于科研通互助平台的介绍 1637377